General Information of Drug (ID: DMRFKZ6)

Drug Name
S-(N-propyl-N-hydroxycarbamoyl)glutathione Drug Info
Synonyms CHEMBL129597; S-(N-propyl-N-hydroxycarbamoyl)glutathione; SCHEMBL3286977; BDBM50092829
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
10740201
TTD Drug ID
DMRFKZ6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BAICALEIN DM4C7E6 Influenza virus infection 1E30-1E32 Phase 2 [2]
Naringenin DMHAZLM N. A. N. A. Phase 1 [2]
2-Sulfhydryl-Ethanol DMJBO3D Discovery agent N.A. Investigative [3]
Kaempferol DMHEMUB Discovery agent N.A. Investigative [2]
S-(N-butyl-N-hydroxycarbamoyl)glutathione DMU7EQV Discovery agent N.A. Investigative [1]
S-(N-heptyl-N-hydroxycarbamoyl)glutathione DMV6T1Q Discovery agent N.A. Investigative [1]
S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione DM1AHIW Discovery agent N.A. Investigative [3]
S-(N-pentyl-N-hydroxycarbamoyl)glutathione DM4E9J2 Discovery agent N.A. Investigative [1]
S-(N-methyl-N-hydroxycarbamoyl)glutathione DM1C9W3 Discovery agent N.A. Investigative [1]
S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione DM3FXPV Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lactoylglutathione lyase (GLO1) TTV9A7R LGUL_HUMAN Inhibitor [1]

References

1 Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I. J Med Chem. 2000 Oct 19;43(21):3981-6.
2 Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. Bioorg Med Chem. 2008 Apr 1;16(7):3969-75.
3 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.